The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication
Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study of Metformin for the Assessment of Changes in Functional Capacity, Endothelial Function, and Hemodynamics in Individuals With Peripheral Artery Disease-Related Intermittent Claudication
Sponsor: Baker Heart and Diabetes Institute
Terminated
The trial has been terminated due to difficulties with recruitment.
Other terminated trials from Baker Heart and Diabetes Institute
- Hypertension · Phase PHASE4 · Mar 2015
- Hypertension · Phase PHASE4 · Oct 2013
- Central Arterial Pressure · Phase PHASE4 · Nov 2011
See all terminations from Baker Heart and Diabetes Institute
Other Intermittent Claudication trials with similar outcome
Listed as NCT01799057, this PHASE4 trial focuses on Intermittent Claudication and Peripheral Arterial Disease and remains terminated or withdrawn. Sponsored by Baker Heart and Diabetes Institute, it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE4
-
Jun 2018 — Nov 2020 [monthly]
Terminated PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE4
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baker Heart and Diabetes Institute
For direct contact, visit the study record on ClinicalTrials.gov .